Unknown OBSERVATIONAL NCT04309383

ShuntCheck Performance Characteristics in Asymptomatic Pseudotumor Cerebri Patients

Assessment of ShuntCheck Performance Characteristics in Asymptomatic Patients With Pseudotumor Cerebri

Sponsor: NeuroDx Development

Interventions ShuntCheck

Updated 7 times since 2020 Last updated: May 30, 2022 Started: Oct 29, 2019 Primary completion: Jun 30, 2024 Completion: Jan 31, 2025

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Pseudotumor Cerebri and is currently ongoing. NeuroDx Development leads this study, which shows 7 recorded versions since 2019 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

Change History

7 versions recorded

Feb 2025 — Present [monthly]

Unknown

Status: Recruiting → Unknown
Sep 2024 — Feb 2025 [monthly]

Recruiting
Jul 2024 — Sep 2024 [monthly]

Recruiting
Jul 2022 — Jul 2024 [monthly]

Recruiting
May 2021 — Jul 2022 [monthly]

Recruiting

▶ Show 2 earlier versions

Jan 2021 — May 2021 [monthly]

Recruiting
Apr 2020 — Jan 2021 [monthly]

Recruiting

First recorded

Oct 2019

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

NeuroDx Development
University of South Florida

Data source: University of South Florida

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Tampa, United States